THE MERCK VETERINARY MANUAL
Print Topic

Sections

Chapters

Antitussive Drugs

-
-

A cough is a sudden, explosive exhalation of air that functions to clear material from the airways. Coughing is one way in which the lungs and airways are protected from inhaled particles. Coughing sometimes brings up sputum (also called phlegm), a mixture of mucus, debris, and cells expelled from the lungs. The cough reflex has both sensory (afferent) and motor (efferent) pathways. The internal laryngeal nerve carries the sensory information away from the area above the glottis in the trachea to the cough center located in the medulla oblongata via the vagus nerve. Stimulation of this area by dust or foreign particles produces a cough to remove the foreign material from the respiratory tract before it reaches the lungs. Mucus production in the bronchi is an airway defense mechanism, and it increases with inflammation and infection. So coughing in dogs and cats occurs because of a primary disease process, such as Bordatella bronchiseptica infection ("kennel cough") or chronic bronchitis in dogs, or feline asthma or heartworm-associated respiratory disease in cats. In most cases, addressing the primary disease will resolve the cough. Antitussive therapy is symptomatic and is primarily for the comfort of the animal and the owner. Most antitussive drugs are opiates or opioids that directly suppress the cough center in the medulla oblongata (see Table 1: Antitussive DrugsTables). The antitussive effect does not appear to be related to the binding of traditional opiate receptors (mu and kappa). For example, dextromethorphan is an opioid derivative with good antitussive activity, but it does not have activity at opiate receptors and is not analgesic or addictive.

Table 1

PrintOpen table in new window Open table in new window

Morphine is an effective antitussive at doses lower than those that produce analgesia and sedation. It is not commonly used for antitussive activity because of adverse effects and the potential for abuse and addiction. Morphine has poor oral bioavailability due to a significant first-pass effect by the liver.

Codeine is methylmorphine; methylation of morphine significantly improves the oral bioavailability by reducing the first-pass effect. Codeine phosphate and codeine sulfate are found in many preparations, including tablets, liquids, and syrups. Codeine has analgesic effects that are about one-tenth that of morphine, but its antitussive potency is about equal to that of morphine. The adverse effects of codeine are significantly less than those seen with morphine at antitussive doses. Toxicity (especially in cats) is exhibited as excitement, muscular spasms, convulsions, respiratory depression, sedation, and constipation. Codeine should not be used after GI tract surgery because of its effects on intestinal motility. The potential for addiction and abuse of codeine is considerably lower than that for morphine.

Hydrocodone is chemically and pharmacologically similar to codeine but more potent. It is combined with an anticholinergic drug (homatropine) to discourage abuse by people. It can be prescribed for small animals but should be used with caution in cats.

Dextromethorphan is technically not considered an opiate, because it does not bind to traditional opiate receptors and is not addictive or analgesic. It is the d-isomer of levorphanol. The l-isomer of levorphanol has addictive and analgesic properties. Although it is recommended anecdotally for the treatment of cough, a pharmacokinetic study in dogs demonstrated a short elimination half-life, rapid clearance, and poor oral bioavailability, making its use as an orally administered cough suppressant in dogs questionable.

Butorphanol, an opioid agonist-antagonist, is used as an analgesic and antitussive in dogs. As an antitussive in dogs, butorphanol is 4 times more potent than morphine and 100 times more potent than codeine. At antitussive dosages, it may produce considerable sedation in dogs. Because butorphanol has poor bioavailability, the oral dose in dogs is 10 times the SC dose. In cats, butorphanol is primarily used as an injectable analgesic. In some cats, it may cause pain on injection, as well as mydriasis, disorientation, swallowing/licking, and sedation.

Last full review/revision October 2014 by Patricia M. Dowling, DVM, MSc, DACVIM, DACVCP

Copyright     © 2009-2015 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use    Permissions